zepbound/mounjaro/tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly F.D.A. Approves New Obesity Drug

Research shows that by the time you hit middle age, your NAD+ levels may already be half of what they were in your 20s

Probiotics may support gut health, though evidence for their efficacy in medication-induced gastrointestinal symptoms remains limited

However, the FAERS (FDA Adverse Event Reporting System) received reports of alopecia or hair loss in people taking semaglutide and other GLP-1 medications like tirzepatide (Mounjaro, Zepbound)

Our best-selling peptide combo for healing, recovery, and getting back to what you love doing

It affects the entire compounding industry and every patient who relies on compounded GLP-1 medications

Generally, weight loss attributed to Semaglutide will start around week 5